Abstract
Introduction
To evaluate the impact of specialized neurocritical care on the population admitted to a neurovascular center and on the outcome of patients with severe aneurysmal subarachnoid hemorrhage (aSAH).
Methods
After exclusion of patients treated with endovascular techniques, between 1999 and 2003, 198 patients with aSAH treated with early aneurysm clipping were analysed. In 1999, a new standardized protocol for intensive care treatment was established in the Department of Neurosurgery, University Hospital Zurich. The results were compared to the earlier time period (1993–1994) immediately after introduction of early aneurysm clipping.
Results
Out of 198 patients with aSAH, 90 patients (45.5%) suffered from mild aSAH World Federation of Neurosurgical Societies (WFNS) grade 1 and 2, 41 (27.3%) from aSAH WFNS grade 3, 36 (18.2%) from grade 4, and 57 (28.8%) from grade 5. From 1999 to 2003, significantly more patients with severe aSAH WFNS grade 4 and 5 underwent (further) treatment (93 out of 198 patients; 47.0%) compared to the former time-period after introduction of early surgery (23 out of 150 patients; 15.3%) (p<0.0001). In the early series, 10 out of 23 patients (43.5%) with WFNS 4 recovered with good outcome Glasgow Outcome Score 4 and 5, whereas in the later series 23 out of 36 (63.9%) with WFNS grade 4 survived in a good functional state. Before 1999, all patients with WFNS grade 5 died or survived in a vegetative state. From 1999 to 2003, 20 out of 57 patients (35.1%) with aSAH WFNS grade 5 survived with good outcome.
Conclusions
The availability of extended specialized neurocritical care seems to induce a change within the patient population towards a higher severity grade. Patients with high-grade aSAH might benefit most from highly specialized neurocritical care treatment.
Similar content being viewed by others
References
Yasargil MG. Clinical Considerations. In: Yasargil MG, ed. Microneurosurgery. Clinical Considerations Surgery of the Intracranial Aneurysms and Results, Volume II, New York: Theme, 1984, pp. 1–32.
Yonekawa Y, Imhof HG, Ogata N, et al. Aneurysm surgery in the acute stage: results of structured treatment. Neurol Med Chir (Tokyo) (Suppl) 1998;38:45–49.
Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 2000;55:258–265.
Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke 2005;36:583–587.
Wong GK, Poon WS. Use of phenytoin and other antconvulsant prophyxis in patients with aneurysmal subarachnoid hemorrhage. Stroke 2005;36:2532.
Naval NS, Stevens RD, Mirski MA, Bhardwaj A. Controversies in the management of aneurysmal subarachnoid hemorrhage. Review. Crit Care Med 2006;34:511–524.
Stover JF, Stocker R. Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998;54:529–534.
Keller E, Schwarz S, Schwab S, Hacke W. Konservative Therapie-massnahmen bei erhöhtem Hirndruck. Intensivmed 1998;35: 252–260.
Gasser S, Khan N, Yonekawa Y, Imhof HG, Keller E. Long-term hypothermia in patients with severe brain edema after poor-grade subarachnoid hemorrhage. Feasibility and intensive care complications. J Neurosurg Anesthesiol 2003;15:240–248.
Keller E, Imhof HG, Gasser S, Terzic A, Yonekawa Y. Endovascular cooling with heat exchange cateheters: a new method to induce and maintain hypothermia. Intensive Care Med 2003;29:939–943.
Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y. Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1998;89: 93–100.
Keller E, Steiner T, Fandino J, Schwab S, Hacke W. Jugular venous oxygen saturation thresholds in trauma patients may not extrapolate to ischemic stroke patients: lessons from a preliminary study. J Neurosurg Anesthesiol 2002;14:130–136.
Keller E, Nadler A, Alkadhi H, Kollias S, Yonekawa Y, Niederer P. Noninvasive measurement of regional cerebral blood flow and regional cerebral blood volume by near-infrared spectroscopy and indocyanine green dye dilution. Neuroimage 2003;20: 828–839.
D'Ambrosio AL, Sughrue ME, Yorgason JG, et al. Decompressive hemicraniectomy for poor-grade aneurysmal subarachnoid hemorrhage patients with associated intracerebral hemorrhage: clinical outcome and quality of life assessment. Neurosurgery 2005;56:12–20.
Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage Neurosurgery 1999;44:1237–1248.
Hegner T, Krayenbuhl N, Hefti M, Yonekawa Y, Keller E. Bedside monitoring of cerebral blood flow in subarachnoid hemorrhage. Acta Neurochir Suppl 2001;77:131–134.
Wintermark M, Ko NU, Smith WS, Liu S, Higashida RT, Dillon WP. Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol 2006;27:26–34.
Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the mangement of aneurysmal subarachnoid haemorrhage. Review. Lancet Neurol 2003;2:614–621.
Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 1983;12:658–661.
Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage. Stroke 2000;31:383–391.
Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982;11:337–343.
Kaku T, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1993;77: 842–847.
Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 1: incidence and effects. J Clin Neurosci 1994;1:19–26.
Barker FG, Ogilvie CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis. J Neurosurg 1996;84:405–414.
Finfer SR, Ferch R, Morgan MK. Barbiturate coma for severe refractory vasospasm following subarachnoid haemorrhage. Intensive Care Med 1999;25:406–409.
Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18:365–372.
Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Review. Curr Opin Crit Care 2002;8:128–133.
Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1999;91:947–952.
Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. Review. N Engl J Med 2006;354:387–396.b
Krayenbuhl N, Hegner T, Yonekawa Y, Keller E. Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new hemodynamic parameters. Acta Neurochir Suppl 2000;77:247–250.
Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Review. Trends Endocrinol Metab 2003;14:182–187
Wijdicks EF, Vermeulen M, van Brummelen P, van Gijn J. The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg 1988;90:209–214.
Schuknecht B. Endovascular treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2005;94:47–51.
Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry 1981;44:285–293.
Kassell NF, Torner JC, Haley EC, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg 1990;73:18–36.
Kassell NF, Torner JC, Jane JA, Haley EC, Adams HP. The International Cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg 1990;73:37–47.
Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume after subarachnoid hemorrhage. Stroke 2003;34:956–960.
Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001;29:635–640.
Patel HC, Menon DK, Tebbs S, Hawker R, Hutchinson PJ, Kirkpatrick PJ. Specialist neurocritical care and outcome from head injury. Intensive Care Med 2002;28:547–553.
Organised inpatient (stroke unit) care for stroke. Stroke Unit Traialists' Collaboration. Review. Cochrane Database Syst Rev 2000;CD000197.
Menon D. Neurocritical care: turf label, organizational construct, or clinical asset? Review. Curr Opin Crit Care 2004;10: 91–93.
Mayer SA. Intensive care management of subarachnoid hemorrhage. Curr Opin Anaesthesiol 1995;8:139–144.
Ropper AH. Neurological intensive care. Ann Neurol 1992;32: 564–569.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lerch, C., Yonekawa, Y., Murol, C. et al. Specialized neurocritical care, severity grade, and outcome of patients with aneurysman subarachnoid hemorrhage. Neurocrit Care 5, 85–92 (2006). https://doi.org/10.1385/NCC:5:2:85
Issue Date:
DOI: https://doi.org/10.1385/NCC:5:2:85